Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period

Because of the physiological changes inherent in pregnancy, pregnant women with lower respiratory tract infections often have more worrisome outcomes compared to non-pregnant individuals, including a higher rate of hospital and intensive care unit admissions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year–43 year

Sex eligibility

Female

Study type

Observational

Primary location

Service Clinico biologique d'Assistance Médicale à La Procréation

Strasbourg, 67091, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient included in a Medically Assisted Procreation (MAR) protocol aged between 18 and 43 years of age
Patient who has already signed a consent to management

Exclusion criteria

Patient who expressed opposition to participating in the study

Treatment and study plan

Primary outcomes

Study of the evolution of pregnancies in the first trimester following MAR management during a COVD-19 pandemic period

Time frame: 12th week of Amenorrhea

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

Evaluation of the Evolution of Pregnancies in the First Trimester Following a Medically Assisted Procreation (MAR) Management During a COVD-19 Pandemic Period

Acronym: AMPCOVID-19

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Jun 4, 2020
Registry last updated: Apr 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed